DAPA-HF results transform dapagliflozin from antidiabetic to heart failure drug
PARIS – Proof that dapagliflozin significantly helped heart failure patients without diabetes recategorizes the drug as a major agent for treating HFrEF.
Related Articles
ACC, HRS and SCAI Concerned by LAAO Cuts, Despite Temporary Reimbursement Increases in Proposed Physician Fee Schedule – American College of Cardiology
Contact: Katie Glenn, kglenn@acc.org, Today the presidents of the American College of Cardiology, Heart Rhythm Society and Society for Cardiovascular Angiography and Interventions made the…
Rise in CV Risk Factors Tied to Vulnerable Plaque in ACS Patients
Using OCT to look at the burden, not just individual factors, helps provide clues on why disease develops—and how it manifests.
Consistent Physical Activity Linked to Reduced All-Cause, CVD Mortality
FRIDAY, July 11, 2025 (HealthDay News) — Consistently and increasingly accumulated physical activity (PA) is associated with a reduced risk for all-cause and c
Stress Testing Picks Up ‘Novel Risk Patterns’ in Stable CAD Patients: ISCHEMIA
Patients with abnormal findings had worse outcomes down the road. Still unknown is exactly how to modify that risk.
MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed
The data indicate it’s worth a shot to try TEER in many with secondary MR, but clinical judgement is critical.
No Benefit of Sentinel Device During TAVI: Updated Meta-analysis
Some believe that future studies are still needed to tease out whether there are high-risk subgroups who will benefit.
Good Outcomes, Little Hospital Experience: Pascal TEER in Real World
The study led to questions about whether patients would be best served by being treated at high-volume centers of excellence.
‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use
Responding to MAUDE data, some have safety concerns but others aren’t surprised to see more events in higher-risk patients.
Underexpanded Acurate Valves Come With Higher Stroke Risk, Study Confirms
Though the Acurate neo and neo2 valves are no longer available, there are lessons here for other self-expanding TAVI platforms.
Greater Frailty Means More Complications, Higher Mortality After PCI
Clinicians should assess frailty more formally before PCI, so the knowledge can help guide discussions with patients, say experts.